Most Active InvestorsFind investorsBlogPricing
Start for free
Start for free
Red Tree Venture Capital logo

Red Tree Venture Capital

North America, California, United States, Portola

Description

Red Tree Venture Capital operates as a venture capital firm that focuses on entrepreneurs developing first-in-class.

Investor Profile

Red Tree Venture Capital has backed more than 13 startups, with 1 new investments in the last 12 months alone. The firm has led 4 rounds, about 31% of its total and boasts 1 exits across its portfolio.

Investment Focus Highlights

  • Concentrates on Series A, Series C, Seed rounds (top funding stages).
  • Majority of deals are located in United States.
  • Strong thematic focus on Biotechnology, Health Care, Life Science.

Stage Focus

  • Series A (38%)
  • Series C (23%)
  • Seed (15%)
  • Series B (15%)
  • Series Unknown (8%)

Country Focus

  • United States (100%)

Industry Focus

  • Biotechnology
  • Health Care
  • Life Science
  • Therapeutics
  • Medical
  • Biopharma
  • Oncology
  • Health Diagnostics
  • Pharmaceutical
  • Genetics
circle-line
FAQ

Frequently Asked Questions

Learn who this investor regularly partners with—both firms and angels—and explore their latest activity.

Who does Red Tree Venture Capital frequently co-invest with?

Omega Funds
Omega Funds
Europe, Geneve, Switzerland, Geneva
Co-Investments: 2
Bioqube Ventures
Bioqube Ventures
Europe, Limburg, Belgium, Hasselt
Co-Investments: 2
RA Capital Management
RA Capital Management
North America, Massachusetts, United States, Boston
Co-Investments: 3
PH
Piper Heartland Healthcare Capital
North America, Minnesota, United States, Minneapolis
Co-Investments: 3
F-Prime Capital
F-Prime Capital
North America, Massachusetts, United States, Cambridge
Co-Investments: 3
Acorn Bioventures
Acorn Bioventures
North America, New York, United States, New York
Co-Investments: 2
PremjiInvest
PremjiInvest
Asia, Karnataka, India, Bangalore
Co-Investments: 2
Eight Roads Ventures
Eight Roads Ventures
Europe, England, United Kingdom, London
Co-Investments: 3
Janus Henderson Investors
Janus Henderson Investors
Europe, England, United Kingdom, London
Co-Investments: 3
Invus
Invus
North America, New York, United States, New York
Co-Investments: 2

What are some of recent deals done by Red Tree Venture Capital?

Excellergy

Palo Alto, California, United States

Excellergy develops portfolio of trifunctional effector cell response inhibitors (ECRIs) to combat severe allergic diseases.

BiotechnologyHealth CareMedical
Series AOct 13, 2025
Amount Raised: $70,000,000
Kivu Bioscience

San Francisco, California, United States

Kivu Bioscience is a biotechnology company that focuses on developing next-generation antibody-drug conjugates to target cancer.

BiotechnologyHealth CareOncology
Series AOct 28, 2024
Amount Raised: $92,000,000
Engrail Therapeutics

San Diego, California, United States

Engrail Therapeutics is a developer of medicines to transform the lives of patients with life-limiting diseases of the nervous system.

Health CareLife ScienceMedicalPharmaceutical
Series BMar 19, 2024
Amount Raised: $157,000,000
Bicara Therapeutics

Cambridge, Massachusetts, United States

Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.

BiopharmaBiotechnologyLife ScienceOncologyTherapeutics
Series CDec 12, 2023
Amount Raised: $165,000,000
Bicara Therapeutics

Cambridge, Massachusetts, United States

Bicara Therapeutics develops dual-action cancer therapies, combining targeted treatments with tumor modulators for enhanced impact.

BiopharmaBiotechnologyLife ScienceOncologyTherapeutics
Series BMar 6, 2023
Amount Raised: $108,000,000
CARGO Therapeutics

San Mateo, California, United States

CARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.

BiotechnologyMedicalTherapeutics
Series AMar 1, 2023
Amount Raised: $200,000,000
Tachyon Therapeutics

San Francisco, California, United States

Tachyon Therapeutics develops novel, selective compounds to improve the treatment of cancer.

BiotechnologyHealth CareLife ScienceMedical
Series AMar 1, 2023
Amount Raised: $11,600,000
Alladapt Immunotherapeutics

Menlo Park, California, United States

Alladapt Immunotherapeutics is a privately held biopharmaceutical company developing prescription therapeutics targeting food allergy.

Biotechnology
Series UnknownJun 22, 2022
Amount Raised: $119,000,000
Rondo Therapeutics

Hayward, California, United States

Rondo Therapeutics creates novel bispecific antibodies that activate the immune system to fight cancer.

BiopharmaBiotechnologyHealth CareLife Science
Series AMar 2, 2022
Amount Raised: $67,000,000
CARGO Therapeutics

San Mateo, California, United States

CARGO Therapeutics develops an adoptive cell therapy to benefit patients from potentially curative treatment options.

BiotechnologyMedicalTherapeutics
SeedJan 1, 2022

Find More Investors Like Red Tree Venture Capital

Discover similar investors in our database and build your perfect investor list.

series_a InvestorsInvestors in PortolaBrowse All InvestorsTop Investors

Need help with your fundraising strategy?Read our fundraising guides

Decorative background shape
Decorative background shape

Ready to Raise Capital?

Founders in our network have raised from Y Combinator, Sequoia, a16z, and more. You could be next.

Find investors

Pages

Most Active Investors Find InvestorsNewsletterPricing

Free tools

Pre-Money and Post-Money Valuation Calculator

Investors By Location

San FranciscoNew York CityBostonLos AngelesChicagoLondonParisIndiaSingaporeTel Aviv

Investors By Stage

Angel InvestorsPre-Seed InvestorsSeed InvestorsSeries A InvestorsSeries B InvestorsSeries C InvestorsSeries D Investors
Red Tree Venture Capital | Pipeseed